US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 3.050
  • +0.240+8.54%
Close Nov 25 16:00 ET
  • 3.050
  • 0.0000.00%
Post 16:02 ET
129.66MMarket Cap-1532P/E (TTM)

About Repare Therapeutics Company

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

Company Profile

SymbolRPTX
Company NameRepare Therapeutics
Listing DateJun 19, 2020
Issue Price20.00
Founded2016
CEOMr. Lloyd M. Segal
MarketNASDAQ
Employees179
Fiscal Year Ends12-31
Address7171 Frederick-Banting,Suite 270
CitySaint-Laurent
ProvinceQuébec
CountryCanada
Zip CodeH4S 1Z9
Phone1-857-412-7018
Websitehttp://www.reparerx.com

Company Executives

  • Name
  • Position
  • Salary
  • Lloyd M. Segal
  • President, Chief Executive Officer and Director
  • 4.99M
  • Dr. Maria Koehler, M.D.,PhD
  • Executive Vice President and Chief Medical Officer
  • 2.09M
  • Steve Forte
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.93M
  • Michael Zinda, PhD
  • Executive Vice President and Chief Scientific Officer
  • --
  • Thomas Civik
  • Chairman of the Board
  • 291.49K
  • Dr. Steven H. Stein, M.D.
  • Director
  • --
  • Ann D. Rhoads
  • Independent Director
  • 274.74K
  • Dr. David P. Bonita, M.D.
  • Independent Director
  • 265.41K
  • Carol A. Schafer
  • Independent Director
  • 272.99K
  • Dr. Samarth Kulkarni, PhD
  • Independent Director
  • 265.31K
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 664.86K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data